Walmart settles for $50M over pharmacies filling invalid prescriptions: DOJ
Key Points:
- Walmart has agreed to a $50 million settlement over allegations that its pharmacies illegally filled thousands of opioid and controlled substance prescriptions, according to the DOJ and DEA.
- The government complaint accused Walmart of violating the Controlled Substances Act by filling invalid prescriptions with knowledge of pharmacists and its compliance team since June 2013.
- Despite pharmacists reporting illegal activity through thousands of refusal-to-fill forms, Walmart’s compliance team prioritized sales and patient awareness over regulatory compliance.
- The settlement requires Walmart to establish a hotline for reporting suspected illegal activity and to proactively monitor pharmacy dispensing patterns.
- Walmart has not yet responded to requests for comment regarding the settlement.